A Multiple Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SRK-001 in Healthy Participants
Clinical trial NCT05156034 · TERMINATED
Trial details
- NCT number
- NCT05156034
- Sponsor
- Sarkana Pharma Inc
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-21
- Primary completion
- 2022-09-05
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.